2020-08269. Importer of Controlled Substances Application: United States Pharmacopeial Convention  

  • Start Preamble

    ACTION:

    Notice of application.

    DATES:

    Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 20, 2020. Such persons may also file a written request for a hearing on the application on or before May 20, 2020.

    ADDRESSES:

    Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.34(a), this is notice that on March 4, 2020, United States Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville, Maryland 20852, applied to be registered as an importer of the following basic class(es) of controlled substances:

    Controlled substanceDrug codeSchedule
    Methamphetamine1105II
    Cathinone1235I
    Phenmetrazine1631II
    Methylphenidate1724II
    Amobarbital2125II
    Pentobarbital2270II
    Secobarbital2315II
    Glutethimide2550II
    Methaqualone2565I
    Lysergic acid diethylamide7315I
    4-Methyl-2,5-dimethoxyamphetamine7395I
    3,4-Methylenedioxyamphetamine7400I
    4-Methoxyamphetamine7411I
    Phencyclidine7471II
    ANPP (4-Anilino-N-phenethyl-4-piperidine)8333II
    Phenylacetone8501II
    Alphaprodine9010II
    Anileridine9020II
    Cocaine9041II
    Codeine-N-oxide9053I
    Start Printed Page 21888
    Dihydrocodeine9120II
    Difenoxin9168I
    Diphenoxylate9170II
    Heroin9200I
    Levomethorphan9210II
    Levorphanol9220II
    Meperidine9230II
    Dextropropoxyphene, bulk (non-dosage forms)9273II
    Morphine-N-oxide9307I
    Thebaine9333II
    Norlevorphanol9634I
    Oxymorphone9652II
    Noroxymorphone9668II
    Alfentanil9737II
    Sufentanil9740II

    The company plans to import the bulk control substances for distribution of analytical reference standards to its customers for analytical testing of raw materials.

    Start Signature

    William T. McDermott,

    Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2020-08269 Filed 4-17-20; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
04/20/2020
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2020-08269
Dates:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 20, 2020. Such persons may also file a written request for a hearing on the application on or before May 20, 2020.
Pages:
21887-21888 (2 pages)
Docket Numbers:
Docket No. DEA-617
PDF File:
2020-08269.pdf